On September 4, 2026, the warehouse of pharmaceutical company Teva on Ukrainian territory was struck twice during a Russian attack. This was announced by the company itself in an official Facebook post, which was cited by the RBC-Ukraine outlet. According to Teva, the two strikes that hit the facility caused no injuries among personnel: all of the company's employees are safe. Nevertheless, the incident once again raises the question of the systematic nature of attacks on Ukraine's pharmaceutical infrastructure, which, amid the ongoing conflict, remains critically important for ensuring the population's access to medicines.
Company response: staff safety and continuity of supplies
In its statement, Teva emphasized that the company is supporting colleagues directly affected by the attack, ensuring their safety, and providing all necessary psychological and organizational assistance. At the same time, Teva assured that it continues to operate, since "millions of people need their medicines, and for many, regular treatment is a daily necessity." The company is currently assessing the consequences of the attack and taking all possible measures to minimize the impact on supply chains, so that Ukrainian patients retain access to the medicines they need. The specific scale of material damage and the timeline for restoring the warehouse's operational capacity were not disclosed at the time of publication.
Teva's position in the Ukrainian pharmaceutical market
Teva is one of the largest international pharmaceutical companies present in Ukraine and ranks among the top three leaders of the domestic pharmaceutical market. The company employs more than 350 staff members and produces over 250 generic and original medicines. The scale of Teva's operations makes any damage to its production and logistics infrastructure significant not only for the corporation itself but for the country's entire healthcare system, where demand for certain drugs is chronic and continuous.
Not the first strike on pharmaceutical logistics
The attack on the Teva warehouse was not the first in recent days to hit objects in the pharmaceutical sector. The day before, on September 3, the "Biokon" complex — one of the country's largest specialized pharmaceutical warehouses, located in the Borispil district and covering an area of about 30,000 square meters — caught fire as a result of a Russian attack in the Kyiv region. The combination of these incidents indicates that the logistics and warehousing capacities of pharmaceutical producers are increasingly coming under fire, creating a direct threat to the sustainability of the population's drug supply.
Contradictory data
No significant discrepancies in the key facts were found in the provided sources: both outlets — RBC-Ukraine and NV Business — confirm the double strike on the Teva warehouse and the absence of casualties. At the same time, the exact location of the damaged warehouse is not specified in open reports, and the scale of material damage and the degree of impact on current supplies remain undefined at the time of publication. The company has promised to provide additional information following its assessment, which leaves some details of the incident unconfirmed for now.
The situation with attacks on pharmaceutical infrastructure in Ukraine continues to remain one of the most vulnerable aspects of civilian security. Damage to the warehousing and production capacities of pharmaceutical companies, amid limited stockpiles and logistical difficulties, can lead to shortages of specific drugs in regions where they are critically needed for chronic patients. International partners and regulators are monitoring the development of events; however, at this point, the priority for Teva and Ukrainian authorities remains restoring the operational capacity of the damaged facilities and guaranteeing uninterrupted patient access to treatment.
